PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.\', \'Faculty of Health Sciences, University of Macau. Taipa, Macau, China.\', \'Department of Allergy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.\', \'Department of Medical Laboratory, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.7150/ijbs.58825
?:doi
?:hasPublicationType
?:journal
  • International journal of biological sciences
is ?:pmid of
?:pmid
?:pmid
  • 33907520
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.686
?:rankingScore_hIndex
  • 64
is ?:relation_isRelatedTo_publication of
?:title
  • Krebs Von den Lungen-6 as a predictive indicator for the risk of secondary pulmonary fibrosis and its reversibility in COVID-19 patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all